Asthma research in Europe: a transformative agenda for innovation and competitiveness. Issue 5 (2nd May 2017)

• Record Type: Journal Article
• Authors: Papadopoulos, Nikolaos G.; Androutsopoulou, Aggeliki; Akdis, Cezmi; Dahlén, Sven-Erik; Djukanovic, Ratko; Edwards, Jessica; Garcia-Marcos, Luis; Johnston, Sebastian L.; Kupczyk, Maciek; Martin, Thomas R.; Myles, David; Palkonen, Susanna; Powell, Pippa; Riley, John; Walker, Samantha
• Is Part Of: European respiratory journal. Volume 49:Issue 5(2017)
• Publication Date: 2017-05-02
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.02294-2016
• Languages: English
• ISSNs: 0903-1936

Abstract

Asthma is highly prevalent, often starting in infancy and persisting throughout life, and is associated with high morbidity and burden. It is a major global health challenge with growing impact, affecting more than 300 million people worldwide and at least 10% of all Europeans [1]. Furthermore, it is the most prevalent long-term condition in children [2]. Approximately 5–10% of asthma cases are so severe that current treatments do not work, and over five million people in the European Union (EU) fall into this category. Asthma research in Europe: a transformative agenda for innovation and competitiveness http://ow.ly/YssR30aNG9h